Literature DB >> 1965288

Clinical study of the anticaries efficacy of three fluoride dentifrices containing anticalculus ingredients: three-year (final) results.

L W Ripa1, G S Leske, C W Triol, A R Volpe.   

Abstract

A 3-year double blind clinical trial was conducted to compare the caries inhibition of an A.D.A.-accepted fluoride dentifrice to the caries inhibitions provided by three fluoride dentifrices containing anticalculus agents. All dentifrices used a compatible silicon dioxide abrasive system. The initial mean age of the subjects was 9.9 yrs and they resided in F-deficient (F less than 0.3 ppm) communities on Long Island, NY. Caries activity in all groups was low with the average annual increment being less than one surface. There were no statistically significant differences in any of the dental parameters tested, DMFS, DMFT, and buccolingual, mesiodistal and occlusal surface increments. It was concluded that the presence of anticalculus agents, specifically soluble pyrophosphates, zinc chloride and zinc oxide, do not interfere with the caries inhibition benefits of fluoride in a compatible dentifrice formulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965288

Source DB:  PubMed          Journal:  J Clin Dent        ISSN: 0895-8831


  3 in total

1.  Fluoride toothpastes of different concentrations for preventing dental caries.

Authors:  Tanya Walsh; Helen V Worthington; Anne-Marie Glenny; Valeria Cc Marinho; Ana Jeroncic
Journal:  Cochrane Database Syst Rev       Date:  2019-03-04

Review 2.  Zinc in the mouth, its interactions with dental enamel and possible effects on caries; a review of the literature.

Authors:  Richard J M Lynch
Journal:  Int Dent J       Date:  2011-08       Impact factor: 2.607

3.  Effects of a sodium fluoride- and phytate-containing dentifrice on remineralisation of enamel erosive lesions-an in situ randomised clinical study.

Authors:  Jonathan E Creeth; Charles R Parkinson; Gary R Burnett; Susmita Sanyal; Frank Lippert; Domenick T Zero; Anderson T Hara
Journal:  Clin Oral Investig       Date:  2018-02-08       Impact factor: 3.573

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.